Wordt geladen...
Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated with Pulmonary Hypertension Therapy in Pediatric Patients
Because most medications for pediatric pulmonary hypertension (PH) are used off label and based on adult trials, little information is available on pediatric-specific adverse events (AEs). Although drug manufacturers are required to submit postmarket AE reports to the Food and Drug Administration (F...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3783558/ https://ncbi.nlm.nih.gov/pubmed/23532466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00246-013-0688-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|